RT Journal Article
SR Electronic
T1 468 Characteristics of toripalimab: a next generation anti-PD-1 antibody with potent T cell activation and enhanced clinical efficacy irrespective of PD-L-1 status
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A522
OP A526
DO 10.1136/jitc-2023-SITC2023.0468
VO 11
IS Suppl 1
A1 Ravindranathan, Sruthi
A1 Wang, Xiaoguang
A1 Chin, Daniel J
A1 Tseng, Su-Yi
A1 Klakamp, Scott
A1 Widmann, Kate
A1 Kapoor, Varun
A1 Vexler, Vladimir
A1 Keegan, Patricia
A1 Yao, Sheng
A1 Khare, Sanjay D
A1 LaVallee, Theresa
A1 Rajasekaran, Narendiran
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A522.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.